← Back to Search

Cognitive Training for Depression

N/A

Waitlist Available

Research Sponsored by Rebecca Price

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during first 6 months

Awards & highlights

Study Summary

This trial seeks to test if computer-based training can help improve depression in patients already receiving esketamine treatment. If successful, this could lead to better, more widespread treatments for depression.

Who is the study for?

This trial is for patients aged 18-80 who are already receiving esketamine treatment for depression at the Center for Interventional Psychiatry. They must plan to stay in the Pittsburgh area for at least a month after joining and should not have intellectual or developmental disabilities that would prevent participation in study activities.Check my eligibility

What is being tested?

The study is examining if cognitive training delivered through a computer can enhance the effectiveness of ongoing esketamine treatment in depressed patients. Participants will be randomly assigned to receive either actual cognitive training or sham (fake) training.See study design

What are the potential side effects?

While this trial focuses on cognitive training, side effects may arise from ongoing esketamine treatments, which can include dissociation, dizziness, nausea, sedation, increased blood pressure, anxiety and headache.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during first month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during first month

This trial's timeline: 3 weeks for screening, Varies for treatment, and during first month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Montgomery Asberg Depression Rating Scale

Quick Inventory of Depressive Symptoms

Secondary outcome measures

Clinical Global Impression Scale--Improvement

Clinical Global Impression Scale--Severity

Frequency of scheduled esketamine visits

+2 more

Other outcome measures

Client Satisfaction Questionnaire

Ease of use

Future likelihood of using Cognitive Training

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Cognitive TrainingExperimental Treatment1 Intervention

8 sessions of web-based cognitive training

Group II: Sham TrainingPlacebo Group1 Intervention

8 sessions of web-based sham training

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Cognitive Training

2008

Completed Phase 3

~4100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rebecca PriceLead Sponsor

6 Previous Clinical Trials

628 Total Patients Enrolled

2 Trials studying Depression

197 Patients Enrolled for Depression

University of PittsburghLead Sponsor

1,719 Previous Clinical Trials

16,342,301 Total Patients Enrolled

119 Trials studying Depression

34,055 Patients Enrolled for Depression

Media Library

Cognitive Training Clinical Trial Eligibility Overview. Trial Name: NCT05719909 — N/A

Depression Research Study Groups: Cognitive Training, Sham Training

Depression Clinical Trial 2023: Cognitive Training Highlights & Side Effects. Trial Name: NCT05719909 — N/A

Cognitive Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05719909 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor accepting volunteers who are over sixty years of age?

"As per the specified inclusion criteria, only individuals aged between 18 and 80 can participate in this medical trial. For those below the age of consent and seniors above 65 years old respectively, there are 171 studies and 849 trials available to them."

Answered by AI

Is there any way for me to be included in this medical research?

"This trial is actively seeking out 40 subjects with depression aged between 18 and 80. All prospective participants must go through the Center for Interventional Psychiatry's existing screening protocols, while conforming to the given age range and two additional study-specific requirements."

Answered by AI

Is there currently recruitment for this research study?

"According to clinicaltrials.gov, this trial is not recruiting at present; the initial posting was on February 1st 2023 and it has been last edited on January 30th 2023. On the other hand, 1134 additional trials are presently open for enrolment."

Answered by AI

What are the stated aims of this clinical research project?

"This clinical trial's primary aim is to measure the Quick Inventory of Depressive Symptoms progression from baseline through 1 month. Other secondary objectives include evaluating Clinical Global Impression Scale--Improvement and Severity, as well as Frequency of scheduled esketamine visits based on clinicians' judgement and patient preferences."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment

Rebecca Price 2023. "Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05719909.